TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group
- 1 July 2007
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 8 (7), 613-624
- https://doi.org/10.1016/s1470-2045(07)70144-4
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Frequency and Cost of Chemotherapy-Related Serious Adverse Effects in a Population Sample of Women With Breast CancerJNCI Journal of the National Cancer Institute, 2006
- Symptom Clusters and Quality of Life in Survivors of Lung CancerOncology Nursing Forum, 2006
- Dealing With a Deluge of Data: An Assessment of Adverse Event Data on North Central Cancer Treatment Group TrialsJournal of Clinical Oncology, 2005
- Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck CancerJournal of Clinical Oncology, 2005
- Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Radiation Therapy Oncology Group Phase II Trial 99-14Journal of Clinical Oncology, 2005
- Preliminary Results of Radiation Therapy Oncology Group 97-03: A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and NeckJournal of Clinical Oncology, 2004
- The Need for Adverse Effects Reporting Standards in Oncology Clinical TrialsJournal of Clinical Oncology, 2004
- CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatmentSeminars in Radiation Oncology, 2003
- An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck CancerJournal of Clinical Oncology, 2003
- Survey of Modalities of Toxicity Assessment and Reporting in Noncomparative Prospective Studies of Chemotherapy in Breast CancerJournal of Clinical Oncology, 2002